A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)

NCT01385566 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous
BIOLOGICAL: ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose Subcutaneous
BIOLOGICAL: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Intradermal
BIOLOGICAL: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal
BIOLOGICAL: Full Dose Intradermal Placebo
BIOLOGICAL: Intradermal Placebo

Sponsor

Merck Sharp & Dohme LLC